Cargando…

Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial

INTRODUCTION: Anxiety and depression have increased markedly during the COVID-19 pandemic. There is a lack of evidence-based strategies to address these mental health needs during the pandemic. OBJECTIVE: We aim to conduct a proof-of-concept trial of the efficacy of a brief group-based psychological...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryant, Richard A., Dawson, Katie S., Keyan, Dharani, Azevedo, Suzanna, Yadav, Srishti, Tran, Jenny, Rawson, Natasha, Harvey, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820421/
https://www.ncbi.nlm.nih.gov/pubmed/34875669
http://dx.doi.org/10.1159/000520283
_version_ 1784646219441635328
author Bryant, Richard A.
Dawson, Katie S.
Keyan, Dharani
Azevedo, Suzanna
Yadav, Srishti
Tran, Jenny
Rawson, Natasha
Harvey, Samuel
author_facet Bryant, Richard A.
Dawson, Katie S.
Keyan, Dharani
Azevedo, Suzanna
Yadav, Srishti
Tran, Jenny
Rawson, Natasha
Harvey, Samuel
author_sort Bryant, Richard A.
collection PubMed
description INTRODUCTION: Anxiety and depression have increased markedly during the COVID-19 pandemic. There is a lack of evidence-based strategies to address these mental health needs during the pandemic. OBJECTIVE: We aim to conduct a proof-of-concept trial of the efficacy of a brief group-based psychological intervention delivered via videoconferencing for adults in Australia distressed by the pandemic. METHODS: In this single-blind, parallel, randomised controlled trial, adults who screened positive for COVID-related psychological distress across Australia were randomly allocated to either a 6-session group-based program based on behavioural principles (n = 120) or enhanced usual care (EUC, n = 120). Primary outcome was total score on the Hospital Anxiety and Depression (HADS) anxiety and depression subscales assessed at baseline, 1 week posttreatment, 2 months (primary outcome time point), and 6 months after treatment, as well as secondary outcome measures of worry, sleep impairment, anhedonia, mood, and COVID-19-related stress. RESULTS: Between May 20, 2020, and October 20, 2020, 240 patients were enrolled into the trial. Relative to EUC, at 2 months participants receiving intervention showed greater reduction on anxiety (mean difference, 1.4 [95% CI, 0.3 to 2.6], p = 0.01; effect size, 0.4 [95% CI, 0.1 to 0.7]) and depression (mean difference, 1.6 [95% CI, 0.4 to 2.8], p = 0.009; effect size, 0.4 [95% CI, 0.2 to 0.7]) scales. These effects were maintained at 6 months. There were also greater reductions of worry, anhedonia, COVID-19-related fears, and contamination fears. CONCLUSIONS: This trial provides initial evidence that brief group-based behavioural intervention delivered via videoconferencing results in moderate reductions in common psychological problems arising during the COVID-19 pandemic. This program may offer a viable and scalable means to mitigate the rising mental health problems during the pandemic.
format Online
Article
Text
id pubmed-8820421
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-88204212022-02-09 Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial Bryant, Richard A. Dawson, Katie S. Keyan, Dharani Azevedo, Suzanna Yadav, Srishti Tran, Jenny Rawson, Natasha Harvey, Samuel Psychother Psychosom Standard Research Article INTRODUCTION: Anxiety and depression have increased markedly during the COVID-19 pandemic. There is a lack of evidence-based strategies to address these mental health needs during the pandemic. OBJECTIVE: We aim to conduct a proof-of-concept trial of the efficacy of a brief group-based psychological intervention delivered via videoconferencing for adults in Australia distressed by the pandemic. METHODS: In this single-blind, parallel, randomised controlled trial, adults who screened positive for COVID-related psychological distress across Australia were randomly allocated to either a 6-session group-based program based on behavioural principles (n = 120) or enhanced usual care (EUC, n = 120). Primary outcome was total score on the Hospital Anxiety and Depression (HADS) anxiety and depression subscales assessed at baseline, 1 week posttreatment, 2 months (primary outcome time point), and 6 months after treatment, as well as secondary outcome measures of worry, sleep impairment, anhedonia, mood, and COVID-19-related stress. RESULTS: Between May 20, 2020, and October 20, 2020, 240 patients were enrolled into the trial. Relative to EUC, at 2 months participants receiving intervention showed greater reduction on anxiety (mean difference, 1.4 [95% CI, 0.3 to 2.6], p = 0.01; effect size, 0.4 [95% CI, 0.1 to 0.7]) and depression (mean difference, 1.6 [95% CI, 0.4 to 2.8], p = 0.009; effect size, 0.4 [95% CI, 0.2 to 0.7]) scales. These effects were maintained at 6 months. There were also greater reductions of worry, anhedonia, COVID-19-related fears, and contamination fears. CONCLUSIONS: This trial provides initial evidence that brief group-based behavioural intervention delivered via videoconferencing results in moderate reductions in common psychological problems arising during the COVID-19 pandemic. This program may offer a viable and scalable means to mitigate the rising mental health problems during the pandemic. S. Karger AG 2022-01 2021-12-07 /pmc/articles/PMC8820421/ /pubmed/34875669 http://dx.doi.org/10.1159/000520283 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Standard Research Article
Bryant, Richard A.
Dawson, Katie S.
Keyan, Dharani
Azevedo, Suzanna
Yadav, Srishti
Tran, Jenny
Rawson, Natasha
Harvey, Samuel
Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial
title Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial
title_full Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial
title_fullStr Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial
title_full_unstemmed Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial
title_short Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial
title_sort effectiveness of a videoconferencing-delivered psychological intervention for mental health problems during covid-19: a proof-of-concept randomized clinical trial
topic Standard Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820421/
https://www.ncbi.nlm.nih.gov/pubmed/34875669
http://dx.doi.org/10.1159/000520283
work_keys_str_mv AT bryantricharda effectivenessofavideoconferencingdeliveredpsychologicalinterventionformentalhealthproblemsduringcovid19aproofofconceptrandomizedclinicaltrial
AT dawsonkaties effectivenessofavideoconferencingdeliveredpsychologicalinterventionformentalhealthproblemsduringcovid19aproofofconceptrandomizedclinicaltrial
AT keyandharani effectivenessofavideoconferencingdeliveredpsychologicalinterventionformentalhealthproblemsduringcovid19aproofofconceptrandomizedclinicaltrial
AT azevedosuzanna effectivenessofavideoconferencingdeliveredpsychologicalinterventionformentalhealthproblemsduringcovid19aproofofconceptrandomizedclinicaltrial
AT yadavsrishti effectivenessofavideoconferencingdeliveredpsychologicalinterventionformentalhealthproblemsduringcovid19aproofofconceptrandomizedclinicaltrial
AT tranjenny effectivenessofavideoconferencingdeliveredpsychologicalinterventionformentalhealthproblemsduringcovid19aproofofconceptrandomizedclinicaltrial
AT rawsonnatasha effectivenessofavideoconferencingdeliveredpsychologicalinterventionformentalhealthproblemsduringcovid19aproofofconceptrandomizedclinicaltrial
AT harveysamuel effectivenessofavideoconferencingdeliveredpsychologicalinterventionformentalhealthproblemsduringcovid19aproofofconceptrandomizedclinicaltrial